Literature DB >> 26299815

Detection of Patients at High Risk of Medication Errors: Development and Validation of an Algorithm.

Eva Aggerholm Saedder1, Marianne Lisby2, Lars Peter Nielsen1, Jørgen Rungby3, Ljubica Vukelic Andersen1, Dorthe Krogsgaard Bonnerup4, Birgitte Brock5.   

Abstract

Medication errors (MEs) are preventable and can result in patient harm and increased expenses in the healthcare system in terms of hospitalization, prolonged hospitalizations and even death. We aimed to develop a screening tool to detect acutely admitted patients at low or high risk of MEs comprised by items found by literature search and the use of theoretical weighting. Predictive variables used for the development of the risk score were found by the literature search. Three retrospective patient populations and one prospective pilot population were used for modelling. The final risk score was evaluated for precision by the use of sensitivity, specificity and area under the ROC (receiver operating characteristic) curves. The variables used in the final risk score were reduced renal function, the total number of drugs and the risk of individual drugs to cause harm and drug-drug interactions. We found a risk score in the prospective population with an area under the ROC curve of 0.76. The final risk score was found to be quite robust as it showed an area under the ROC curve of 0.87 in a recent patient population, 0.74 in a population of internal medicine and 0.66 in an orthopaedic population. We developed a simple and robust score, MERIS, with the ability to detect patients and divide them according to low and high risk of MEs in a general population admitted at acute admissions unit. The accuracy of the risk score was at least as good as other models reported using multiple regression analysis.
© 2015 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26299815     DOI: 10.1111/bcpt.12473

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  10 in total

1.  Risk of prescribing errors in acutely admitted patients: a pilot study.

Authors:  Dorthe Krogsgaard Bonnerup; Marianne Lisby; Eva Aggerholm Sædder; Charlotte Arp Sørensen; Birgitte Brock; Ljubica Andersen; Anette Gjetrup Eskildsen; Lars Peter Nielsen
Journal:  Int J Clin Pharm       Date:  2016-07-09

2.  Development of Screening Tools to Predict Medication-Related Problems Across the Continuum of Emergency Department Care: A Prospective, Multicenter Study.

Authors:  Simone E Taylor; Elise A Mitri; Andrew M Harding; David McD Taylor; Adrian Weeks; Leonie Abbott; Pani Lambros; Dona Lawrence; Dana Strumpman; Reyhan Senturk-Raif; Stephen Louey; Hamish Crisp; Emily Tomlinson; Elizabeth Manias
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

3.  Effects of stratified medication review in high-risk patients at admission to hospital: a randomised controlled trial.

Authors:  Dorthe Krogsgaard Bonnerup; Marianne Lisby; Eva Aggerholm Sædder; Birgitte Brock; Tania Truelshøj; Charlotte Arp Sørensen; Anita Gorm Pedersen; Lars Peter Nielsen
Journal:  Ther Adv Drug Saf       Date:  2020-09-20

4.  Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission: A Randomized Clinical Trial.

Authors:  Lene Vestergaard Ravn-Nielsen; Marie-Louise Duckert; Mia Lolk Lund; Jolene Pilegaard Henriksen; Michelle Lyndgaard Nielsen; Christina Skovsende Eriksen; Thomas Croft Buck; Anton Pottegård; Morten Rix Hansen; Jesper Hallas
Journal:  JAMA Intern Med       Date:  2018-03-01       Impact factor: 21.873

5.  High-risk medicines associated with clinically relevant medication-related problems in UK hospitals: A prospective observational study.

Authors:  Cathy Geeson; Li Wei; Bryony Dean Franklin
Journal:  Br J Clin Pharmacol       Date:  2019-12-17       Impact factor: 4.335

6.  Systematic review of predictive risk models for adverse drug events in hospitalized patients.

Authors:  Nazanin Falconer; Michael Barras; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2018-02-22       Impact factor: 4.335

7.  Validation of the assessment of risk tool: patient prioritisation technology for clinical pharmacist interventions.

Authors:  Nazanin Falconer; Doreen Liow; Irene Zeng; Nirasha Parsotam; Mary Seddon; Sanjoy Nand
Journal:  Eur J Hosp Pharm       Date:  2017-05-16

8.  Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists' input to improve patient outcomes. Protocol for an observational study.

Authors:  Cathy Geeson; Li Wei; Bryony Dean Franklin
Journal:  BMJ Open       Date:  2017-06-14       Impact factor: 2.692

9.  Development and performance evaluation of the Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists' input to prevent medication-related problems.

Authors:  Cathy Geeson; Li Wei; Bryony Dean Franklin
Journal:  BMJ Qual Saf       Date:  2019-03-07       Impact factor: 7.035

Review 10.  Systematic Review of Risk Factors Assessed in Predictive Scoring Tools for Drug-Related Problems in Inpatients.

Authors:  Lea Jung-Poppe; Hagen Fabian Nicolaus; Anna Roggenhofer; Anna Altenbuchner; Harald Dormann; Barbara Pfistermeister; Renke Maas
Journal:  J Clin Med       Date:  2022-09-01       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.